Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance

Area of Science:

• Oncology
• Pharmacology

Background:

• Multidrug resistance (MDR) significantly hinders cancer chemotherapy efficacy.
• ATP-binding cassette (ABC) transporters, like P-glycoprotein (P-gp), were initially the primary focus for overcoming MDR.
• Clinical success of specific ABC transporter inhibitors has been limited, necessitating alternative strategies.

Purpose of the Study:

• To review drugs developed to overcome MDR and cancer stem cells (CSCs).
• To discuss the limitations and future perspectives of targeting CSCs for MDR.
• To provide insights into novel therapeutic approaches for refractory cancers.

Main Methods:

• Literature review of studies on MDR and CSCs.
• Analysis of drugs targeting both MDR mechanisms and CSCs.
• Discussion of clinical trial outcomes and preclinical findings.

Main Results:

• Overexpression of ABC transporters is a key MDR mechanism, but inhibitors have shown limited clinical success.
• Cancer stem cells (CSCs) exhibit inherent MDR properties, contributing to cancer recurrence and progression.
• Emerging research focuses on CSC-targeting agents to overcome MDR.

Conclusions:

• Targeting CSCs represents a promising avenue for overcoming MDR in cancer treatment.
• Further research is needed to develop effective CSC-targeting drugs with improved clinical applicability.
• A combination of MDR and CSC-targeting strategies may offer enhanced therapeutic benefits.